| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $307.7M | +25.9% |
| Cost of Revenue | $135.2M | +29.3% |
| Gross Profit | $172.5M | +23.4% |
| R&D Expense | $106.7M | +5.7% |
| SG&A Expense | $88.1M | +14.2% |
| Operating Income | -$95.1M | +18.1% |
| Pre-tax Income | -$242.2M | -100.6% |
| Income Tax | $4.7M | +89.2% |
| Net Income | -$246.9M | -100.4% |
| EPS (Basic) | -$0.80 | -90.5% |
| EPS (Diluted) | -$0.80 | -90.5% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $229.4M | +94.4% |
| Accounts Receivable | $83.5M | +49.6% |
| Inventory | $6.1M | — |
| Current Assets | $775.4M | +156.6% |
| Total Assets | $1.15B | +80.8% |
| Current Liabilities | $469.5M | +230.4% |
| Total Liabilities | $957.3M | +397.2% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $134.4M | +1034.8% |
| Capital Expenditures | $76.7M | +73.2% |
| Investing Cash Flow | -$393.1M | -778.9% |
| Financing Cash Flow | $357.1M | +2398.4% |
| Free Cash Flow | $57.6M | +198.3% |
| $188.4M |
| -57.3% |